Efficacy of 1.25 MG versus 2.5 MG intravitreal bevacizumab for diabetic macular edema: six-month results of a randomized controlled trial. (Q51768441)
Jump to navigation
Jump to search
scientific article published in March 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Efficacy of 1.25 MG versus 2.5 MG intravitreal bevacizumab for diabetic macular edema: six-month results of a randomized controlled trial. |
scientific article published in March 2009 |
Statements
Efficacy of 1.25 MG versus 2.5 MG intravitreal bevacizumab for diabetic macular edema: six-month results of a randomized controlled trial. (English)
1 reference
Dennis S C Lam
1 reference
Timothy Y Y Lai
1 reference
Vincent Y W Lee
1 reference
Carmen K M Chan
1 reference
David T L Liu
1 reference
Shaheeda Mohamed
1 reference
Chi-Lai Li
1 reference
1 March 2009
1 reference
1 reference
29
1 reference
3
1 reference
292-299
1 reference